Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04832438
Title 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Actuate Therapeutics Inc.
Indications

salivary gland carcinoma

Therapies

9-ING-41 + Carboplatin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.